Healthcare provider profile · identity verified

Mark A. Schleupner, M.D.

Internal Medicine · ROANOKE, VA · NPI 1467434944

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	386	108
Atorvastatin Calcium	Atorvastatin Calcium	342	102
Levothyroxine Sodium	Levothyroxine Sodium	239	69
Omeprazole	Omeprazole	235	71
Albuterol Sulfate Hfa	Albuterol Sulfate	227	50
Furosemide	Furosemide	207	63
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	198	36
Hydrochlorothiazide	Hydrochlorothiazide	190	55
Gabapentin	Gabapentin	189	43
Lisinopril	Lisinopril	189	54
Losartan Potassium	Losartan Potassium	177	56
Ozempic	Semaglutide	176	31
Metformin Hcl	Metformin Hcl	173	46
Pantoprazole Sodium	Pantoprazole Sodium	168	56
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	147	44
Trazodone Hcl	Trazodone Hcl	146	38
Simvastatin	Simvastatin	134	43
Metoprolol Tartrate	Metoprolol Tartrate	129	43
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	115	37
Eliquis	Apixaban	112	26
Meloxicam	Meloxicam	108	36
Tramadol Hcl	Tramadol Hcl	107	27
Famotidine	Famotidine	106	37
Spironolactone	Spironolactone	104	34
Tamsulosin Hcl	Tamsulosin Hcl	104	33
Fluticasone Propionate	Fluticasone Propionate	97	34
Rosuvastatin Calcium	Rosuvastatin Calcium	94	33
Metoprolol Succinate	Metoprolol Succinate	89	32
Carvedilol	Carvedilol	86	25
Allopurinol	Allopurinol	82	25
Lorazepam	Lorazepam	77	18
Potassium Chloride	Potassium Chloride	76	25
Pravastatin Sodium	Pravastatin Sodium	76	27
Clopidogrel	Clopidogrel Bisulfate	75	24
Breo Ellipta	Fluticasone/Vilanterol	73	12
Trulicity	Dulaglutide	72	18
Citalopram Hbr	Citalopram Hydrobromide	70	24
Clonazepam	Clonazepam	69	12
Alprazolam	Alprazolam	67	15
Sertraline Hcl	Sertraline Hcl	67	23
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	65	23
Topiramate	Topiramate	65	15
Tizanidine Hcl	Tizanidine Hcl	61	20
Buspirone Hcl	Buspirone Hcl	55	14
Duloxetine Hcl	Duloxetine Hcl	55	17
Promethazine Hcl	Promethazine Hcl	54	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	15
Tresiba Flextouch U-200	Insulin Degludec	53	11
Diclofenac Sodium	Diclofenac Sodium	52	20
Montelukast Sodium	Montelukast Sodium	52	12
Mirtazapine	Mirtazapine	50	16
Pregabalin	Pregabalin	50	11
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	49	suppressed
Farxiga	Dapagliflozin Propanediol	44	13
Terazosin Hcl	Terazosin Hcl	44	17
Bupropion Xl	Bupropion Hcl	43	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	43	13
Ibuprofen	Ibuprofen	42	13
Atenolol	Atenolol	40	13
Jardiance	Empagliflozin	40	suppressed
Klor-Con M20	Potassium Chloride	40	14
Celecoxib	Celecoxib	39	12
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Glipizide	Glipizide	38	12
Escitalopram Oxalate	Escitalopram Oxalate	37	11
Azelastine Hcl	Azelastine Hcl	36	12
Amitriptyline Hcl	Amitriptyline Hcl	34	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	34	suppressed
Januvia	Sitagliptin Phosphate	34	suppressed
Lansoprazole	Lansoprazole	34	suppressed
Ezetimibe	Ezetimibe	32	13
Metformin Hcl Er	Metformin Hcl	32	13
Levetiracetam	Levetiracetam	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	11
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	30	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Lovastatin	Lovastatin	28	suppressed
Prednisone	Prednisone	28	17
Wixela Inhub	Fluticasone Propion/Salmeterol	28	suppressed
Colchicine	Colchicine	27	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	27	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Memantine Hcl	Memantine Hcl	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Cephalexin	Cephalexin	25	21
Chlorthalidone	Chlorthalidone	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Synthroid	Levothyroxine Sodium	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	23	suppressed
Oxycodone Hcl	Oxycodone Hcl	23	suppressed
Tresiba Flextouch U-100	Insulin Degludec	23	suppressed
Valsartan	Valsartan	23	suppressed
Hydralazine Hcl	Hydralazine Hcl	22	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Linzess	Linaclotide	19	suppressed
Nitroglycerin	Nitroglycerin	19	14
Ondansetron Odt	Ondansetron	19	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	19	suppressed
Alendronate Sodium	Alendronate Sodium	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Amoxicillin	Amoxicillin	17	16
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Acetazolamide	Acetazolamide	15	suppressed
Desmopressin Acetate	Desmopressin Acetate	15	suppressed
Diazepam	Diazepam	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Doxepin Hcl	Doxepin Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Estradiol	Estradiol	14	suppressed
Finasteride	Finasteride	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Risperidone	Risperidone	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Azithromycin	Azithromycin	12	11
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Efavirenz-Emtric-Tenofov Disop	Efavirenz/Emtricit/Tenofovr Df	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Baclofen	Baclofen	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Nexium	Esomeprazole Magnesium	11	suppressed
Nystatin	Nystatin	11	suppressed
Xifaxan	Rifaximin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error